ArticleViewAbstractPharmacognosy Journal,2026,18,2,181-186.DOI:10.5530/pj.2026.18.132Published:June 2026Type:Original ArticleTotal Phenolic and Flavonoid Contents, Antioxidant and Antiinflammatory Activities of Phellinus rimosus ExtractsPornpun Laovachirasuwan, Sonesay Thammavong, Khwanruan Naksuwankul, Sounantha suvanlasy, Theera Rittirod, Weerapong Prasongchean, Jidapha Sangmahachai, Sutthipong Chiangtong, Panwad Lerdpiriyasakulkit, Burin T. Sriwong, Piyachet Jatuten, and Methin Phadungkit Pornpun Laovachirasuwan1, Sonesay Thammavong2, Khwanruan Naksuwankul3, Sounantha suvanlasy2, Theera Rittirod4, Weerapong Prasongchean4, Jidapha Sangmahachai4, Sutthipong Chiangtong4, Panwad Lerdpiriyasakulkit4, Burin T. Sriwong5, Piyachet Jatuten6, Methin Phadungkit4* 1Faculty of Pharmacy, Mahasarakham University, THAILAND. 2Faculty of Pharmacy, University of Health Sciences, LAOS PDR. 3Faculty of Science, Mahasarakham University, THAILAND. 4Faculty of Pharmacy, Nakhonratchasima College, THAILAND. 5Faculty of Pharmacy, Silpakorn University, THAILAND. 6Moryathai 101 Co., Ltd., THAILAND. Abstract:Background: Phellinus rimosus is a medicinal mushroom with potential bioactive properties, although scientific evidence supporting its pharmacological activities remains limited. Objective: To investigate the phenolic and flavonoid contents, antioxidant capacity, and anti-inflammatory activity of ethanolic and aqueous extracts of P. rimosus. Materials and Methods: Total phenolic content (TPC) and total flavonoid content (TFC) were determined using colorimetric assays. Antioxidant activity was evaluated by DPPH, ABTS, and FRAP methods. Anti-inflammatory activity was assessed by measuring nitric oxide (NO) inhibition in lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophages. Statistical analysis was performed at P < 0.05. Results: The ethanolic extract contained significantly higher TPC (361.04 ± 5.69 mg GAE/g extract) and TFC (646.55 ± 6.29 mg RE/g extract) than the aqueous extract. It exhibited strong antioxidant activity with IC₅₀ values of 9.56 ± 0.47 μg/mL (DPPH) and 5.40 ± 0.06 μg/mL (ABTS), and a FRAP value of 52.39 ± 0.25 mM Fe²⁺/100 mg extract. The ethanolic extract also significantly inhibited NO production (IC₅₀ = 54.40 ± 2.35 μg/mL) without cytotoxicity, whereas the aqueous extract showed no inhibitory effect. Conclusion: The ethanolic extract of P. rimosus demonstrates notable antioxidant and anti-inflammatory activities and may serve as a promising natural source of bioactive compounds. Keywords:Anti-inflammatory activity, antioxidant activity, Flavonoid content, nitric oxide inhibition, Phellinus rimosus, Phenolic contentView:PDF (239.67 KB) PDF Images Total Phenolic and Flavonoid Contents, Antioxidant and Antiinflammatory Activities of Phellinus rimosus Extracts ‹ Design and Virtual Screening of Dihydropyrimidinone and Chromene-Based Derivatives as Potential SARS-CoV-2 NSP16 Methyltransferase Inhibitors up Pharmacognostic Standardization, Phytochemical Profiling, Antioxidant Activity, and Toxicological Evaluation of the Traditionally Used Medicinal Plant Prunus wallichii Steud. ›